The Decision Record, signed April 10, authorizes two of the three studies proposed last year, a three-year trial of the oocyte growth factor and a five-year test of a new form of porcine zona pellucida known as SpayVac, subject to a 30-day appeal period.
Both products were described as vaccines.
The option to conduct a four-year study of an intrauterine device known as the iUPOD was deferred to a later date, to be approved through a separate decision.
The research will take place at the Northern Nevada Correctional Facility in Carson City, according to today’s news release.
The Final EA and other supporting documents have been copied to the project folder.
RELATED: Draft EA for Fertility Control Research Out for Review.
Western Horse Watchers Association 